Page last updated: 2024-09-05

1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole and allopurinol

1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)
Trials
(1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)
Recent Studies (post-2010)
(1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
130315,0967433,363

Protein Interaction Comparison

ProteinTaxonomy1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, A; Banerjee, UC; Dhar, KL; Gupta, MK; Kumar, R; Nepali, K; Sapra, S; Satti, NK; Singh, G; Suri, OP; Turan, A; Verma, PK1

Other Studies

1 other study(ies) available for 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole and allopurinol

ArticleYear
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
    Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6

    Topics: Binding Sites; Catalytic Domain; Computer Simulation; Drug Design; Enzyme Inhibitors; Isomerism; Pyrazoles; Structure-Activity Relationship; Xanthine Oxidase

2011